Discount sale is live
Logo
Prophylactic Human Vaccine Market
  2. / Market Insights
  3. Table of Content - Prophylactic Human Vaccine Market Analysis
all report title image

Prophylactic Human Vaccine Market, By Vaccine Type (Quadrivalent, Bivalent, Monovalent, Pentavalent, and Others), By Technology Platform (Live Attenuated, Inactivated, Recombinant, mRNA-based, and Others), By Application (Pediatric Immunization, Adult Vaccination, Geriatric Vaccination, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : 19 Nov, 2025
  • Code : CMI2261
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
  • 歴史的範囲: 2020 - 2024
  • 歴史的範囲: 2020 - 2024
Ingographics Image
N/A

Table of Contents

  1. Research Objectives and Assumptions

    • Research Objectives

    • Assumptions

    • Abbreviations

  2. Market Preview

    • Report Description

      • Market Definition and Scope

    • Executive Summary

      • Market Snapshot, By Vaccine Type

      • Market Snapshot, By Technology Platform

      • Market Snapshot, By Application

      • Market Snapshot, By Region

    • Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics

      • Drivers

      • Restraints

      • Market Opportunities

    • Impact Analysis

    • Recent Product Launches

    • Epidemiology

    • Merger, Acquisition, and Collaboration

    • Regulatory Scenario

    • Key Developments

    • PEST Analysis

    • Partnership Scenario

    • Brand and Pricing Analysis

    • Distributors Landscape

    • Porters Analysis

    • Technological Advancements

    • Key Developments

    • Market Trend

    • Future Prospective

    • Top Market Players by Revenue

  4. Prophylactic Human Vaccine Market By Vaccine Type, 2025–2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Quadrivalent

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Bivalent

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Monovalent

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Pentavalent

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  5. Prophylactic Human Vaccine Market By Technology Platform, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Live Attenuated

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Inactivated

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Recombinant

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • mRNA-based

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  6. Prophylactic Human Vaccine Market By Application, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, 2021–2032

      • Segment Trends

    • Pediatric Immunization

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Adult Vaccination

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Geriatric Vaccination

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

    • Others

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, 2025-2032, (US$ Billion)

  7. Prophylactic Human Vaccine Market By Region, 2025-2032, (US$ Billion)

    • Introduction

      • Market Share Analysis, By Region, 2025 and 2032 (%)

      • Y-o-Y Growth Analysis, For Regions, 2021–2032

      • Regional Trends

    • North America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, en2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • U.S.

        • Canada

    • Latin America

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • U.K.

        • Germany

        • Italy

        • France

        • Spain

        • Russia

        • Benelux

        • Denmark

        • Norway

        • Sweden

        • Rest of Europe

    • Asia Pacific

      • Introduction

      • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

        • China

        • Taiwan

        • India

        • Japan

        • Indonesia

        • Malaysia

        • Philippines

        • Singapore

        • Australia

        • South Korea

        • Rest of Asia Pacific

o Middle East & Africa

  • Introduction

  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Technology Platform, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2025-2032, (US$ Billion)

  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2025-2032, (US$ Billion)

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • UAE

    • Israel

    • South Africa

    • North Africa

    • Central Africa

    • Rest of the Middle East

  1. Competitive Landscape

    • Sanofi Pasteur

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Pfizer Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • GlaxoSmithKline plc

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Merck & Co., Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Bharat Biotech International Limited

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Serum Institute of India Pvt. Ltd.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Johnson & Johnson

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Novavax, Inc.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • Sinovac Biotech Ltd.

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • BioNTech SE

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

    • AstraZeneca Plc

      • Company Highlights

      • Product Portfolio

      • Key Highlights

      • Financial Performance

      • Market Strategies

  2. Section

    • Research Methodology

    • About Us

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.